Particle Contamination News
Most Popular Particle Contamination Story
Genzyme: partly cloudy, chance of regulators
Last Friday--the 13th--the FDA sent Genzyme (GENZ) a complete response letter regarding the company's application to market Pompe disease treatment Lumizyme. Tucked into that letter was a condition: Read more...
Latest Headlines
- December 22, 2011
- November 8, 2011
- October 25, 2011
- May 18, 2011
- March 29, 2011
- January 12, 2011
- December 30, 2010
- November 22, 2010
- November 17, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
